Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics

M Schulz, S Iwersen-Bergmann, H Andresen… - Critical care, 2012 - Springer
Introduction In order to assess the significance of drug levels measured in intensive care
medicine, clinical and forensic toxicology, as well as for therapeutic drug monitoring, it is …

Polymorphism of human cytochrome P450 enzymes and its clinical impact

SF Zhou, JP Liu, B Chowbay - Drug metabolism reviews, 2009 - Taylor & Francis
Pharmacogenetics is the study of how interindividual variations in the DNA sequence of
specific genes affect drug response. This article highlights current pharmacogenetic …

Drug interactions with tobacco smoking: an update

S Zevin, NL Benowitz - Clinical pharmacokinetics, 1999 - Springer
Cigarette smoking remains highly prevalent in most countries. It can affect drug therapy by
both pharmacokinetic and pharmacodynamic mechanisms. Enzymes induced by tobacco …

Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance

UM Zanger, K Klein - Frontiers in genetics, 2013 - frontiersin.org
Cytochrome P450 2B6 (CYP2B6) belongs to the minor drug metabolizing P450s in human
liver. Expression is highly variable both between individuals and within individuals, owing to …

Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics

M Schulz, A Schmoldt - Die Pharmazie-An International Journal …, 2003 - ingentaconnect.com
In order to assess the significance of drug levels measured in clinical and forensic toxicology
as well as for Therapeutic Drug Monitoring (TDM) it is essential that good collections of data …

Bupropion is a nicotinic antagonist

JE Slemmer, BR Martin, MI Damaj - The Journal of Pharmacology and …, 2000 - Elsevier
Neuronal nicotinic receptors are ligand-gated ion channels of the central and peripheral
central nervous system that regulate synaptic activity from both pre-and postsynaptic sites …

Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver

T Lang, K Klein, J Fischer, AK Nüssler… - Pharmacogenetics …, 2001 - journals.lww.com
The human cytochrome P450, CYP2B6, is involved in the metabolism of several
therapeutically important drugs and environmental or abused toxicants. In this study, we …

Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations

JW Jefferson, JF Pradko, KT Muir - Clinical therapeutics, 2005 - Elsevier
BACKGROUND:: Major depressive disorder (MDD) is a common psychiatric condition, with
6.6% of the adult population in the United States experiencing a major depressive episode …

Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective

HD Desai, J Seabolt, MW Jann - CNS drugs, 2001 - Springer
Many psychiatric patients smoke, and are believed to be heavier smokers than those without
psychiatric disorders. Cigarette smoking is one of the environmental factors that contributes …

Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity

SR Faucette, RL Hawke, EL Lecluyse, SS Shord… - Drug metabolism and …, 2000 - Elsevier
The purpose of this study was to establish bupropion (BUP) hydroxylation as a selective in
vitro marker of cytochrome P450 (CYP) 2B6 catalytic activity. Among a panel of 16 human …